Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael McIntosh

Showing results (51-60 of 287) with videos related to

Pageof 29
Sort By:
Eneuro|June 17, 2015
Limited efficacy of α-conopeptides, Vc1.1 and RgIA, to inhibit sensory neuron Ca<sub>V</sub> currentAndrew B Wright, Yohei Norimatsu, J Michael McIntosh, et al.
Current Biology : CB|June 27, 2017
Differential Control of Dopaminergic Excitability and Locomotion by Cholinergic Inputs in Mouse Substantia NigraJasem Estakhr, Danya Abazari, Kaitlyn Frisby, et al.
The Journal of Nutrition|December 6, 2008
Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implicationsArion Kennedy, Kristina Martinez, Chia-Chi Chuang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 16, 2011
Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal glandAlberto Pérez-Alvarez, Alicia Hernández-Vivanco, J Michael McIntosh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 26, 2011
Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4* subtypeArik J Hone, Erin L Meyer, Melissa McIntyre, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2012
Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatumTanuja Bordia, Maya Hrachova, Matthew Chin, et al.
Biochemical Pharmacology|May 30, 2009
Alpha9 nicotinic acetylcholine receptors and the treatment of painJ Michael McIntosh, Nathan Absalom, Mary Chebib, et al.
Anesthesia and Analgesia|May 22, 2012
Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in ratsElzbieta P Wala, Peter A Crooks, J Michael McIntosh, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2012
The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain modelsShakir D AlSharari, F Ivy Carroll, J Michael McIntosh, et al.
Journal of Neurophysiology|July 22, 2005
Activation of nicotinic acetylcholine receptors increases the frequency of spontaneous GABAergic IPSCs in rat basolateral amygdala neuronsPing Jun Zhu, Randall R Stewart, J Michael McIntosh, et al.
Pageof 29

Showing results (51-60 of 287) with videos related to

Sort By:
Pageof 29
Eneuro|June 17, 2015
Limited efficacy of α-conopeptides, Vc1.1 and RgIA, to inhibit sensory neuron Ca<sub>V</sub> currentAndrew B Wright, Yohei Norimatsu, J Michael McIntosh, et al.
Current Biology : CB|June 27, 2017
Differential Control of Dopaminergic Excitability and Locomotion by Cholinergic Inputs in Mouse Substantia NigraJasem Estakhr, Danya Abazari, Kaitlyn Frisby, et al.
The Journal of Nutrition|December 6, 2008
Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implicationsArion Kennedy, Kristina Martinez, Chia-Chi Chuang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 16, 2011
Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal glandAlberto Pérez-Alvarez, Alicia Hernández-Vivanco, J Michael McIntosh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 26, 2011
Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4* subtypeArik J Hone, Erin L Meyer, Melissa McIntyre, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2012
Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatumTanuja Bordia, Maya Hrachova, Matthew Chin, et al.
Biochemical Pharmacology|May 30, 2009
Alpha9 nicotinic acetylcholine receptors and the treatment of painJ Michael McIntosh, Nathan Absalom, Mary Chebib, et al.
Anesthesia and Analgesia|May 22, 2012
Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in ratsElzbieta P Wala, Peter A Crooks, J Michael McIntosh, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2012
The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain modelsShakir D AlSharari, F Ivy Carroll, J Michael McIntosh, et al.
Journal of Neurophysiology|July 22, 2005
Activation of nicotinic acetylcholine receptors increases the frequency of spontaneous GABAergic IPSCs in rat basolateral amygdala neuronsPing Jun Zhu, Randall R Stewart, J Michael McIntosh, et al.
Pageof 29